Overcoming Ovarian Cancer Chemoresistance Overcoming Ovarian Cancer Chemoresistance
Cancer Sensitizing Agents for Chemotherapy

Overcoming Ovarian Cancer Chemoresistance

    • $179.99
    • $179.99

Publisher Description

Overcoming Ovarian Cancer Chemoresistance presents non-overlapping review chapters that discuss the state of the field in overcoming chemoresistance of ovarian cancer and treatment options before and following recurrence, considering the genetic makeup of the ovarian cancer patient and her tumor. With the uptake of both germline and somatic gene testing, clinicians can obtain a more comprehensive understanding of ovarian tumors and this book provides information to link the genetic makeup of a tumor (or patient) with the best available treatment.


The book discusses topics such as strategies to fight chemo-resistance in ovarian cancer, circulating DNA as a monitor of response, BRCA mutations, ovarian cancer stem cells, immunotherapy and vaccines. Additionally, it brings a list of promising agents at clinical and pre-clinical stage that will impact the treatment in the near future.


This book is a valuable source for cancer researchers, oncologists and several members of biomedical field who need to understand how to battle chemoresistance in ovarian cancer.




- Provides a comprehensive view of both biological and genetic determinants of resistance, as well as technical approaches to monitor response


- Discusses genetic reversions as a unique alteration and a new field of study


- Includes a chapter on upcoming and promising agents that are in the pre-clinical and early clinical space, to set the stage for future directions in the field

GENRE
Science & Nature
RELEASED
2020
November 6
LANGUAGE
EN
English
LENGTH
188
Pages
PUBLISHER
Academic Press
SELLER
Elsevier Ltd.
SIZE
12.7
MB
Overcoming Drug Resistance in Gynecologic Cancers Overcoming Drug Resistance in Gynecologic Cancers
2021
A Theranostic and Precision Medicine Approach for Female-Specific Cancers A Theranostic and Precision Medicine Approach for Female-Specific Cancers
2020
Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3 Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3
2016
Genomic and Precision Medicine Genomic and Precision Medicine
2022
Anticancer Therapeutics Anticancer Therapeutics
2017
Theranostic Approach for Pancreatic Cancer Theranostic Approach for Pancreatic Cancer
2019
Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance
2020
Therapeutic Strategies to Overcome ALK Resistance in Cancer Therapeutic Strategies to Overcome ALK Resistance in Cancer
2021
New Targeting in The Reversal of Resistant Glioblastomas New Targeting in The Reversal of Resistant Glioblastomas
2021
Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies
2021
Epigenetic Regulation in Overcoming Chemoresistance Epigenetic Regulation in Overcoming Chemoresistance
2021
Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC
2023